Sofinnova Investments, Inc. Inhibrx, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.72 Billion
- Q1 2024
A detailed history of Sofinnova Investments, Inc. transactions in Inhibrx, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 1,302,645 shares of INBX stock, worth $19.7 Million. This represents 2.65% of its overall portfolio holdings.
Number of Shares
1,302,645
Previous 772,957
68.53%
Holding current value
$19.7 Million
Previous $29.4 Million
55.05%
% of portfolio
2.65%
Previous 1.86%
Shares
9 transactions
Others Institutions Holding INBX
# of Institutions
132Shares Held
35.5MCall Options Held
64.8KPut Options Held
91.3K-
Viking Global Investors LP7.15MShares$108 Million0.95% of portfolio
-
Perceptive Advisors LLC New York, NY4.26MShares$64.2 Million3.12% of portfolio
-
Black Rock Inc. New York, NY2.75MShares$41.5 Million0.0% of portfolio
-
State Street Corp Boston, MA2.42MShares$36.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$28.1 Million0.0% of portfolio
About Inhibrx, Inc.
- Ticker INBX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,057,700
- Market Cap $589M
- Description
- Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...